Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • aquleaf
    Member
    • Mar 2010
    • 38

    #1

    HIDATA in Cuffdiff

    Hi all. Sorry to bother you.

    I have a question about Cufflinks suite. Basically, I used Cufflinks to assemble transcripts and genes, then Cuffmerge to merge all the assemblies and generate an annotation and at last Cuffdiff to identify differentially expressed genes. Some genes were marked with HIDATA when using default value of --max-bundle-frags. After increasing the --max-bundle-frags value, there is no gene labled with HIDATA in the gene and transcript assembly step by Cufflinks. However, in Cuffdiff step, I still got HIDATA tag.

    Is there any other arguments should be defined in Cuffdiff step?

    Wish your help! Thanks very much! I really appreciate it.
  • sdriscoll
    I like code
    • Sep 2009
    • 436

    #2
    did you try setting --max-bundle-frags when you ran cuffdiff?
    /* Shawn Driscoll, Gene Expression Laboratory, Pfaff
    Salk Institute for Biological Studies, La Jolla, CA, USA */

    Comment

    • aquleaf
      Member
      • Mar 2010
      • 38

      #3
      Originally posted by sdriscoll View Post
      did you try setting --max-bundle-frags when you ran cuffdiff?
      Yes, I increase --max-bundle-frags in cuffdiff step, but still got HIDATA

      Comment

      • sdriscoll
        I like code
        • Sep 2009
        • 436

        #4
        I can't say for sure but maybe this this is happening in cuffdiff and not Cufflinks because the first thing cuffdiff does is pool all of the alignments from your replicates and quantifies it all at once. They do that to establish a confidence interval against which they can compare replicate expressions to pick out isoforms with outlier expressions so it can skip them in testing. You might just need to raise the --max-bundle-frags setting by a factor equal to the number of samples you're running. Or set it to 999999999. That should be well beyond any single locus' depth.
        Last edited by sdriscoll; 11-13-2012, 09:29 PM.
        /* Shawn Driscoll, Gene Expression Laboratory, Pfaff
        Salk Institute for Biological Studies, La Jolla, CA, USA */

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 08-06-2026, 07:41 AM
        0 responses
        13 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        40 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Working...